Funder: DARPA - Biological Technologies Office
Due Dates: August 28, 2025 (Full proposals)
Funding Amounts: No stated limit; award size and period of performance will vary by proposal and negotiated budget. No indirect cost rate cap applies for this cycle.
Summary: Supports innovative research to develop ingestible neuromodulation and sensing platforms for monitoring and modulating acute stress biomarkers in the small intestine.
Key Information: No 15% indirect cost cap; all responsible sources (including non-U.S.) may apply; UARCs and FFRDCs strongly discouraged from applying as prime/sub.